Fake Ozempic Injections Hospitalize Several in Austria, Raising Counterfeit Drug Concerns Across Europe
Patients subjected to counterfeit Ozempic suffered hypoglycemic attacks and seizures, indicating the presence of insulin instead of the drug's active ingredient, semaglutide; authorities warn against "weight-loss injections" from unregulated sources as global shortages spur the black market.
